Hepatitis A and B screening and vaccination rates among patients with chronic liver disease

Human Vaccines & Immunotherapeutics
Jonathan RamirezDawn M Sears

Abstract

Vaccinations against hepatitis A virus (HAV) and hepatitis B virus (HBV) are recommended for patients with chronic liver disease (CLD), yet implementation of these recommendations is lacking. This study reviewed HAV and HBV antibody testing and vaccination status of patients with CLD. In 2008, we began using pre-printed liver order sets, which included vaccination options. We compared Scott & White liver clinic CLD patient records from 2005 (238) with patient records from 2008 (792). Screening rates for immunity and vaccination rates of those lacking immunity were calculated. In 2005, 66% of CLD patients were screened for HAV immunity. In 2008, 56% of CLD patients were screened. The HAV vaccination completion rate was 37% in 2005, while in 2008, the rate was 46%. In 2005, 66% of CLD patients were screened for HBV immunity; in 2008, 56 % CLD patients were screened. The HBV vaccination completion rate was 26% in 2005 compared with 36% in 2008. Although there was a lower percentage of screening in 2008, the overall number of patients tripled between 2005 and 2008. There was a significant increase in the total number of patients screened and vaccinated in 2008. Some physicians may have vaccinated their patients without checking for...Continue Reading

References

Mar 21, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E B KeeffeD S Krause
Jun 11, 1999·The American Journal of Gastroenterology·J A DumotW D Carey
Jun 30, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M R ArguedasM B Fallon
Dec 21, 2002·Transplantation Proceedings·G A SmallwoodT G Heffron
Jan 19, 2005·Journal of Viral Hepatitis·S SaabA B Ibrahim
Aug 17, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael ShimEdmund J Bini
Aug 23, 2005·Digestive Diseases and Sciences·R Jake JacobsSammy Saab

❮ Previous
Next ❯

Citations

Jun 21, 2018·Human Vaccines & Immunotherapeutics·Parinaz K GhaswallaMei Sheng Duh
Mar 26, 2021·Journal of Viral Hepatitis·Sergio Rodríguez-TajesXavier Forns

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.